[O-33] 一般演題口演セッション33
神経放射線・機能画像・創薬など

[O-33-6] SUNFISH試験：脊髄性筋萎縮症II型／III型患者におけるリスジプラムの有効性及び安全性

^○齋藤 加代子¹, Eugenio Mercuri², Nina Barisic³, Anna Kostera-pruszczyk⁴, Riccardo Masson⁵, Elena Mazzone², Andres Nascimento⁶, Carole Vuillerot⁷, Sabine Fuerst-recktenwald⁸, Marianne Gerber⁸, Ksenija Gorni⁸, Heidemarie Kletzl⁸, Wai Yin Yeung⁹, John W. Day¹⁰ (1.東京女子医科大学 臨床ゲノムセンター, 2.Paediatric Neurology and Nemo Center, Catholic University and Policlinico Gemelli, 3.Clinical Medical Center Zagreb, University of Zagreb Medical School, Department of Paediatrics, 4.Katedra I Klinika Neurologii Warszawskiego Uniwersytetu, 5.Carlo Besta Neurological Research Institute Foundation, Developmental Neurology Unit, 6.Neuromuscular UnLit, Neuropaediatrics Department, Hospital Sant Joan de Déu, Fundacion Sant Joan de Deu, CIBERER - ISC III, 7.Department of Pediatric Physical Medicine and Rehabilitation, Hôpital Mère Enfant, CHU-Lyon, 8.F. Hoffmann-La Roche Ltd., 9.Roche Products Ltd., 10.Department of Neurology, Stanford University)